How AI is reshaping the value chain in the MedTech industry.
Medical technology is on the cusp of a revolution thanks to artificial intelligence (AI). Since the breakthrough of ChatGPT, generative artificial intelligence (GenAI) has been dominating the headlines – and is raising huge expectations, not least in the healthcare and the life sciences sectors. But what in all of this is hype, and what is real? The fact is that the transformative power of AI is available to be harnessed now. It can dramatically shorten development cycles, make production processes smarter and help customise sales. AI is being used to boost innovation, and thus improve patient care and run business operations more efficiently. Yet at the same time, established players in the market are under increasing pressure to act on this development. Newcomers – ranging from agile start-ups to tech giants – are coming into the market armed with AI-based solutions. For decision-makers in the MedTech industry, this means that sitting back to see what happens is not an option. Unless they actively seize the opportunities offered by AI, they risk being left behind. The good news, however, is that the technologies are there and the data is in plentiful supply – so now it’s a matter of moving swiftly to the implementation phase.
AI along the entire value chain
Artificial intelligence reveals its full potential when it is applied across the entire length of a medtech company’s value chain. From research and development (R&D), production and supply chain management to marketing and sales – there are starting points for creating added value every step of the way, and not just with GenAI. For example, AI systems can contribute new design ideas in the early research stages, ensure smoother production processes and anticipate customer needs for sales purposes with pinpoint precision. Numerous companies are already experimenting with and using AI in specific areas. However, the real added value is generated when AI is used in an integrated way and at scale across a range of functions. Leading medtech companies are therefore developing holistic AI strategies that target opportunities in all aspects of the business. Three core areas and the key factors that determine sustainable success are highlighted in this article.
Info
Read the article in full length: Artificial Intelligence in Medical Technology
Jan Boris Wintzenburg
Director Communications and Marketing
Porsche Consulting GmbHjan_boris.wintzenburg@porsche-consulting.comSee AlsoSanara MedTech Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Unaudited)Medtech brands must work hard to build trust in an age of misinformationJ&J’s electrophysiology sales dip amid slow Varipulse startThe transformation imperative: Igniting value creation in medtech
Related Content
Porsche Consulting
Growth requires strong supply chains
Embraer operations manager Luis Marinho on the current boom in the aviation industry.
Porsche Consulting
The Next Wave
Sustainable Fuels and the Eco-Friendly Future of the Maritime Industry
Porsche Consulting
Building Should Be Fun
Entrepreneur Heidi Weber-Mühleck focuses on craftsmanship, sustainability, and efficiency.
Porsche Consulting
More passengers through digitalization
How to make rail transport more attractive and improve reliability
© 2025 Dr. Ing. h.c. F. Porsche AG.
* Where values are indicated as ranges, they do not refer to a single, specific vehicle and are not part of the offered product range. They are only for the purposes of comparison between different vehicle types. Additional equipment and accessories (add-on parts, tyre formats etc.) can change relevant vehicle parameters such as weight, rolling resistance and aerodynamics. These factors, in addition to weather, traffic conditions and driving behaviour, can influence the fuel/electricity consumption, CO2 emissions, range and performance values of a vehicle.
** Important information about the all-electricPorschemodels can be foundhere.
Terms and conditions Porsche Newsroom
1. All information offered on Porsche Newsroom, including but not limited to, texts, images, audio and video documents, are subject to copyright or other legislation for the protection of intellectual property. They are intended exclusively for use by journalists as a source for their own media reporting and are not intended for commercial use, in particular for advertising purposes. It is not permitted to pass on texts, images, audio or video data to unauthorised third parties.
2.Use of Newsroom content for book projects (or similar commercial use) is not permitted, particular with regards to images. Any potential usage must be approved beforehand by Dr. Ing. h.c. F. Porsche AG. To discuss licencing requests for book projects please email:archiv@porsche.de
3. All logos and trademarks mentioned on Porsche Newsroom are trademarks of Dr. Ing. h.c. F. Porsche AG (hereinafter: Porsche AG), unless otherwise stated.
4. All contents of Porsche Newsroom are carefully researched and compiled. Nevertheless, the information may contain errors or inaccuracies. Porsche AG does not accept any liability with respect to the results that may be achived through the use of the information, in particular with respect to accuracy, up-to-dateness and completeness.
5. Insofar as Porsche Newsroom provides information concerning vehicles, the data refers to the German market. Statements concerning standard equipment and statutory, legal and tax regulations and repercussion are valid for the Federal Public of Germany only.
6. With respect to the use of Porsche Newsroom, technical faults such as, delays to news transmission, cannot be ruled out. Porsche AG does not accept any liability for any resulting damage.
7. Insofar as Porsche Newsroom provides links to the internet sites of third parties, Porsche AG does not accept any responsibility for the content of the linked sites. On using the links, the user leaves the Porsche AG information products.
8. In agreeing to these rights of use, the user shall be obliged to refrain from any improper use of Porsche Newsroom.
9. In the event of improper use, Porsche AG reserves the right to block access to Porsche Newsroom.
10. Should one or more provisions of these terms and conditions be or become invalid, this shall not affect the validity of the remaining provisions.
